This interactive map explains where COPD rates, hospitalizations, and deaths are highest across the United States.
Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...
A lung biopsy showed that Thomas’ symptoms ... tolerance — or if they smoke or have an underlying condition such as emphysema — they should see their physician or a pulmonologist, according ...
KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
But what many people don’t realize is that the same low-dose CT scans used to screen for lung cancer can also uncover another life-threatening condition: Emphysema, a form of chronic obstructive ...
Korro Bio disclosed that the Food and Drug Administration granted orphan drug designation to its potential genetic disorder drug KRRO-110. Shares rose 17.6% to $29 in premarket trading. The stock is ...
Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.
For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results